Tracking Cancer Evolution Reveals Constrained Routes to Metastases: TRACERx Renal

Journal: Cell

Published: 2018-04-12

DOI: 10.1016/j.cell.2018.03.057

Affiliations: 22

Authors: 49

Go to article
Institutions FC
Translational Cancer Therapeutics Laboratory, The Francis Crick Institute, United Kingdom (UK) 0.18
Guy's and St Thomas' NHS Foundation Trust, United Kingdom (UK) 0.16
The Royal Marsden Hospital - London, The Royal Marsden NHS Foundation Trust, United Kingdom (UK) 0.14
Ventana Medical Systems, Inc., United States of America (USA) 0.10
Roche Sequencing Solutions (RSS), United States of America (USA) 0.08
University College Hospital (UCH), United Kingdom (UK) 0.05
The Royal Marsden NHS Foundation Trust, United Kingdom (UK) 0.04
Department of Surgery, MSKCC, United States of America (USA) 0.04
Experimental Histopathology, The Francis Crick Institute, United Kingdom (UK) 0.04
CRUK Lung Cancer Centre of Excellence, United Kingdom (UK) 0.02
UCL Cancer Institute, United Kingdom (UK) 0.02
University of the Basque Country (UPV/EHU), Spain 0.02
Bioinformatics and Biostatistics Platform, The Francis Crick Institute, United Kingdom (UK) 0.02
BioCruces Health Research Institute, Spain 0.02
Clínica Universidad de Navarra (CUN), UNAV, Spain 0.02
Marie-Josée and Henry R. Kravis Center for Molecular Oncology, MSKCC, United States of America (USA) 0.02
John T. Milliken Department of Medicine, WUSTL, United States of America (USA) 0.01
Siteman Cancer Center, WUSTL, United States of America (USA) 0.01

Return